Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

STVN vs BCPC

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
STVN
Stevanato Group S.p.A.

Medical - Instruments & Supplies

HealthcareNYSE • IT
Market Cap$4.92B
5Y Perf.-10.7%
BCPC
Balchem Corporation

Chemicals - Specialty

Basic MaterialsNASDAQ • US
Market Cap$5.11B
5Y Perf.+18.2%

STVN vs BCPC — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
STVN logoSTVN
BCPC logoBCPC
IndustryMedical - Instruments & SuppliesChemicals - Specialty
Market Cap$4.92B$5.11B
Revenue (TTM)$1.18B$1.06B
Net Income (TTM)$139M$158M
Gross Margin29.0%36.3%
Operating Margin16.5%21.0%
Forward P/E29.3x30.9x
Total Debt$471M$192M
Cash & Equiv.$131M$75M

STVN vs BCPCLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

STVN
BCPC
StockJul 21May 26Return
Stevanato Group S.p… (STVN)10089.3-10.7%
Balchem Corporation (BCPC)100118.2+18.2%

Price return only. Dividends and distributions are not included.

Quick Verdict: STVN vs BCPC

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: BCPC leads in 7 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
STVN
Stevanato Group S.p.A.
The Specific-Use Pick

In this particular matchup, STVN is outpaced on most metrics by others in the set.

Best for: healthcare exposure
BCPC
Balchem Corporation
The Income Pick

BCPC carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • Dividend streak 11 yrs, beta 0.33, yield 0.5%
  • Rev growth 8.8%, EPS growth 20.9%, 3Y rev CAGR 3.2%
  • 160.5% 10Y total return vs STVN's -7.2%
Best for: income & stability and growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthBCPC logoBCPC8.8% revenue growth vs STVN's 3.2%
ValueBCPC logoBCPCPEG 2.41 vs 2.48
Quality / MarginsBCPC logoBCPC15.0% margin vs STVN's 11.8%
Stability / SafetyBCPC logoBCPCBeta 0.33 vs STVN's 1.45, lower leverage
DividendsBCPC logoBCPC0.5% yield, 11-year raise streak, vs STVN's 0.3%
Momentum (1Y)BCPC logoBCPC-2.2% vs STVN's -17.0%
Efficiency (ROA)BCPC logoBCPC9.4% ROA vs STVN's 5.8%, ROIC 12.2% vs 7.7%

STVN vs BCPC — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

STVNStevanato Group S.p.A.

Segment breakdown not available.

BCPCBalchem Corporation
FY 2025
Product Sales
99.8%$1.0B
Royalty
0.2%$2M

STVN vs BCPC — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLBCPCLAGGINGSTVN

Income & Cash Flow (Last 12 Months)

BCPC leads this category, winning 6 of 6 comparable metrics.

STVN and BCPC operate at a comparable scale, with $1.2B and $1.1B in trailing revenue. Profitability is closely matched — net margins range from 15.0% (BCPC) to 11.8% (STVN). On growth, BCPC holds the edge at +8.1% YoY revenue growth, suggesting stronger near-term business momentum.

MetricSTVN logoSTVNStevanato Group S…BCPC logoBCPCBalchem Corporati…
RevenueTrailing 12 months$1.2B$1.1B
EBITDAEarnings before interest/tax$283M$267M
Net IncomeAfter-tax profit$139M$158M
Free Cash FlowCash after capex$16M$182M
Gross MarginGross profit ÷ Revenue+29.0%+36.3%
Operating MarginEBIT ÷ Revenue+16.5%+21.0%
Net MarginNet income ÷ Revenue+11.8%+15.0%
FCF MarginFCF ÷ Revenue+1.4%+17.2%
Rev. Growth (YoY)Latest quarter vs prior year+3.8%+8.1%
EPS Growth (YoY)Latest quarter vs prior year-5.6%+10.6%
BCPC leads this category, winning 6 of 6 comparable metrics.

Valuation Metrics

STVN leads this category, winning 5 of 7 comparable metrics.

At 31.3x trailing earnings, STVN trades at a 7% valuation discount to BCPC's 33.6x P/E. Adjusting for growth (PEG ratio), BCPC offers better value at 2.62x vs STVN's 2.64x — a lower PEG means you pay less per unit of expected earnings growth.

MetricSTVN logoSTVNStevanato Group S…BCPC logoBCPCBalchem Corporati…
Market CapShares × price$4.9B$5.1B
Enterprise ValueMkt cap + debt − cash$5.3B$5.2B
Trailing P/EPrice ÷ TTM EPS31.31x33.58x
Forward P/EPrice ÷ next-FY EPS est.29.32x30.87x
PEG RatioP/E ÷ EPS growth rate2.64x2.62x
EV / EBITDAEnterprise value multiple16.89x19.83x
Price / SalesMarket cap ÷ Revenue3.68x4.92x
Price / BookPrice ÷ Book value/share2.82x4.14x
Price / FCFMarket cap ÷ FCF195.36x29.51x
STVN leads this category, winning 5 of 7 comparable metrics.

Profitability & Efficiency

BCPC leads this category, winning 8 of 9 comparable metrics.

BCPC delivers a 12.4% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $10 for STVN. BCPC carries lower financial leverage with a 0.15x debt-to-equity ratio, signaling a more conservative balance sheet compared to STVN's 0.32x. On the Piotroski fundamental quality scale (0–9), BCPC scores 9/9 vs STVN's 5/9, reflecting strong financial health.

MetricSTVN logoSTVNStevanato Group S…BCPC logoBCPCBalchem Corporati…
ROE (TTM)Return on equity+9.7%+12.4%
ROA (TTM)Return on assets+5.8%+9.4%
ROICReturn on invested capital+7.7%+12.2%
ROCEReturn on capital employed+9.5%+14.8%
Piotroski ScoreFundamental quality 0–959
Debt / EquityFinancial leverage0.32x0.15x
Net DebtTotal debt minus cash$340M$117M
Cash & Equiv.Liquid assets$131M$75M
Total DebtShort + long-term debt$471M$192M
Interest CoverageEBIT ÷ Interest expense20.54x15.23x
BCPC leads this category, winning 8 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

BCPC leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in BCPC five years ago would be worth $12,424 today (with dividends reinvested), compared to $9,282 for STVN. Over the past 12 months, BCPC leads with a -2.2% total return vs STVN's -17.0%. The 3-year compound annual growth rate (CAGR) favors BCPC at 8.2% vs STVN's -13.8% — a key indicator of consistent wealth creation.

MetricSTVN logoSTVNStevanato Group S…BCPC logoBCPCBalchem Corporati…
YTD ReturnYear-to-date-12.4%+3.6%
1-Year ReturnPast 12 months-17.0%-2.2%
3-Year ReturnCumulative with dividends-35.9%+26.6%
5-Year ReturnCumulative with dividends-7.2%+24.2%
10-Year ReturnCumulative with dividends-7.2%+160.5%
CAGR (3Y)Annualised 3-year return-13.8%+8.2%
BCPC leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

BCPC leads this category, winning 2 of 2 comparable metrics.

BCPC is the less volatile stock with a 0.33 beta — it tends to amplify market swings less than STVN's 1.45 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BCPC currently trades 86.7% from its 52-week high vs STVN's 64.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricSTVN logoSTVNStevanato Group S…BCPC logoBCPCBalchem Corporati…
Beta (5Y)Sensitivity to S&P 5001.45x0.33x
52-Week HighHighest price in past year$28.00$183.90
52-Week LowLowest price in past year$12.89$139.17
% of 52W HighCurrent price vs 52-week peak+64.4%+86.7%
RSI (14)Momentum oscillator 0–10082.132.9
Avg Volume (50D)Average daily shares traded583K190K
BCPC leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

BCPC leads this category, winning 2 of 2 comparable metrics.

Wall Street rates STVN as "Buy" and BCPC as "Buy". Consensus price targets imply 35.9% upside for STVN (target: $25) vs 1.6% for BCPC (target: $162). For income investors, BCPC offers the higher dividend yield at 0.54% vs STVN's 0.34%.

MetricSTVN logoSTVNStevanato Group S…BCPC logoBCPCBalchem Corporati…
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$24.50$162.00
# AnalystsCovering analysts810
Dividend YieldAnnual dividend ÷ price+0.3%+0.5%
Dividend StreakConsecutive years of raises011
Dividend / ShareAnnual DPS$0.05$0.87
Buyback YieldShare repurchases ÷ mkt cap0.0%+2.1%
BCPC leads this category, winning 2 of 2 comparable metrics.
Key Takeaway

BCPC leads in 5 of 6 categories (Income & Cash Flow, Profitability & Efficiency). STVN leads in 1 (Valuation Metrics).

Best OverallBalchem Corporation (BCPC)Leads 5 of 6 categories
Loading custom metrics...

STVN vs BCPC: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is STVN or BCPC a better buy right now?

For growth investors, Balchem Corporation (BCPC) is the stronger pick with 8.

8% revenue growth year-over-year, versus 3. 2% for Stevanato Group S. p. A. (STVN). Stevanato Group S. p. A. (STVN) offers the better valuation at 31. 3x trailing P/E (29. 3x forward), making it the more compelling value choice. Analysts rate Stevanato Group S. p. A. (STVN) a "Buy" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — STVN or BCPC?

On trailing P/E, Stevanato Group S.

p. A. (STVN) is the cheapest at 31. 3x versus Balchem Corporation at 33. 6x. On forward P/E, Stevanato Group S. p. A. is actually cheaper at 29. 3x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Balchem Corporation wins at 2. 41x versus Stevanato Group S. p. A. 's 2. 48x.

03

Which is the better long-term investment — STVN or BCPC?

Over the past 5 years, Balchem Corporation (BCPC) delivered a total return of +24.

2%, compared to -7. 2% for Stevanato Group S. p. A. (STVN). Over 10 years, the gap is even starker: BCPC returned +160. 5% versus STVN's -7. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — STVN or BCPC?

By beta (market sensitivity over 5 years), Balchem Corporation (BCPC) is the lower-risk stock at 0.

33β versus Stevanato Group S. p. A. 's 1. 45β — meaning STVN is approximately 340% more volatile than BCPC relative to the S&P 500. On balance sheet safety, Balchem Corporation (BCPC) carries a lower debt/equity ratio of 15% versus 32% for Stevanato Group S. p. A. — giving it more financial flexibility in a downturn.

05

Which is growing faster — STVN or BCPC?

By revenue growth (latest reported year), Balchem Corporation (BCPC) is pulling ahead at 8.

8% versus 3. 2% for Stevanato Group S. p. A. (STVN). On earnings-per-share growth, the picture is similar: Balchem Corporation grew EPS 20. 9% year-over-year, compared to 14. 0% for Stevanato Group S. p. A.. Over a 3-year CAGR, STVN leads at 5. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — STVN or BCPC?

Balchem Corporation (BCPC) is the more profitable company, earning 14.

9% net margin versus 11. 8% for Stevanato Group S. p. A. — meaning it keeps 14. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BCPC leads at 21. 1% versus 16. 1% for STVN. At the gross margin level — before operating expenses — BCPC leads at 35. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is STVN or BCPC more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Balchem Corporation (BCPC) is the more undervalued stock at a PEG of 2. 41x versus Stevanato Group S. p. A. 's 2. 48x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Stevanato Group S. p. A. (STVN) trades at 29. 3x forward P/E versus 30. 9x for Balchem Corporation — 1. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for STVN: 35. 9% to $24. 50.

08

Which pays a better dividend — STVN or BCPC?

All stocks in this comparison pay dividends.

Balchem Corporation (BCPC) offers the highest yield at 0. 5%, versus 0. 3% for Stevanato Group S. p. A. (STVN).

09

Is STVN or BCPC better for a retirement portfolio?

For long-horizon retirement investors, Balchem Corporation (BCPC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

33), 0. 5% yield, +160. 5% 10Y return). Both have compounded well over 10 years (BCPC: +160. 5%, STVN: -7. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between STVN and BCPC?

These companies operate in different sectors (STVN (Healthcare) and BCPC (Basic Materials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

BCPC pays a dividend while STVN does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

STVN

Stable Dividend Mega-Cap

  • Sector: Healthcare
  • Market Cap > $100B
  • Net Margin > 7%
  • Dividend Yield > 0.5%
Run This Screen
Stocks Like

BCPC

Stable Dividend Mega-Cap

  • Sector: Basic Materials
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 8%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform STVN and BCPC on the metrics below

Revenue Growth>
%
(STVN: 3.8% · BCPC: 8.1%)
Net Margin>
%
(STVN: 11.8% · BCPC: 15.0%)
P/E Ratio<
x
(STVN: 31.3x · BCPC: 33.6x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.